International Cannabis Weekly: 429

UK EXPERTS HAVE PUBLISHED THEIR FIRST COMPREHENSIVE DOSING GUIDE FOR MEDICAL CANNABIS

The Medical Cannabis Clinicians Society (MCCS) has released a landmark guide setting out standardised dosing protocols for cannabis oils, in what the organisation describes as a major step forward for safe, consistent prescribing across the UK.

READ MORE  »

ANANDA HAS DECIDED TO EXIT LANDMARK NHS-FUNDED EPILEPSY TRIAL

READ MORE »

MEDICARE CBD COVERAGE PROPOSED BUT FEDERAL BAN THREATENS ENTIRE INDUSTRY

READ MORE »

• High Tide has made the move to open its first ever European store in Berlin, broadening its physical footprint.
• EU-certified medical vaporizers enter the market, setting a new regulatory standard.
• Kanabo has called in administrators, marking sobering end to LSE cannabis rush.
• Bavaria’s first cultivation association has distributed its harvest amongest its members.
• More people in Wales are turning to medical cannabis for health conditions, data shows.
• Avecho Biotechnology receives US and EU patent allowances for proprietary CBD soft-gel capsule.

GET TICKETS NOW »

• Virginia lawmakers have revealed blueprint for regulated cannabis marketplace.
• Texas set to expand medical THC programme and names nine likely new providers.
• Nebraska Medical Cannabis Commission is working to finalise its latest set of regulations.
• Tennessee officials have reached a deal with hemp industry to temporarily allow THCA sales.
• Minnesota governor has reportedly explored options to respond to federal hemp THC ban.
• The World Health Organisation (WHO) has growing concerns around cannabinoid hyperemesis syndrome.

• New innovations in the cannabis sector are starting to shape the future of Canadian agriculture.
• Sensi Brands Incorporated has finalised a deal to acquire cannabis firm Maricann Inc.
• Alberta cannabis companies fear provincial taxes will significantly reduce local producers.
• MTL Cannabis reports second-quarter revenue of $25.4 million with strong margins and improved balance sheet.
• Canadian firm Ayurcann has reported sales of $14.6 million in its first quarter of 2026.
• Canadian researchers have examined cannabis use trends and impacts, drawing interesting conclusions.
• New Brunswick premier discusses including cannabis in new interprovincial trade agreement.
• Cannabis insurance remains difficult to place but is influencing insurer approaches to new sectors.

• University of Brasília launches cannabis observatory to support national production and map therapeutic use.
• Parliamentary front announces eight winning projects for medical cannabis research grants.
• Costa Rican candidates have moved to debate adult-use cannabis legalisation for 2025.
• Antigua and Barbuda government commits to inclusive growth of medicinal cannabis industry.

• Aurora Cannabis has sealed a partnership with Leafio for Australian distribution.
• Approvals fall as medicinal cannabis sales plateau, a new Penington report finds.
• Chinese investor behind Y Cannabis moves to take full control of Tasmanian Botanics in A$31 million deal.
• New Zealand has made the decision to introduce new cannabis roadside testing measures.

• Zimbabwe identified as ideal location for year-round cannabis and hemp cultivation.
• Researchers explore cannabinoid diversity and nutritional potential in southern Africa.